Marksans Pharma informs about disclosure

02 Apr 2019 Evaluate

In compliance with the SEBI (Prohibition of insider Trading) (Amendment) Regulations, 2018, Marksans Pharma has informed that the Board of directors of the Company has adopted revised Code of Practices and Procedures For Fair Disclosure of Unpublished Price Sensitive Information effective from April 1, 2019. The said revised code is attached herewith and is also available on the Company's website at www.marksanspharma.com.

The above information is a part of company’s filings submitted to BSE.

Marksans Pharma Share Price

184.70 0.75 (0.41%)
08-Dec-2025 15:16 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1796.45
Dr. Reddys Lab 1266.15
Cipla 1499.55
Zydus Lifesciences 925.85
Lupin 2072.35
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×